157
Views
5
CrossRef citations to date
0
Altmetric
Original Articles: Gynaecology

Comparison of two different starting doses of recombinant follicle stimulating hormone (rFSH) for intrauterine insemination (IUI) cycles in non-obese women with polycystic ovary syndrome (PCOS): a retrospective cohort study

ORCID Icon, &

References

  • Balasch J, Fabregues F, Creus M, Casamitjana R, Puerto B, Vanrell JA. 2000. Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol. Journal of Assisted Reproduction and Genetics 17:561–565.
  • Balen A. 2003. Ovulation induction – optimizing results and minimizing risks. Human Fertility 6:S42–S51.
  • Balen AH, Platteau P, Andersen AN, Devroey P, Sørensen P, Helmgaard L, et al. 2006. The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility. BJOG 113:1195–1202.
  • Bruna-Catalan I, Menabrito M, Spanish Collaborative G. 2011. Ovulation induction with minimal dose of follitropin alfa: a case series study. Reproductive Biology and Endocrinology: RB&E 9:142.
  • Calaf Alsina J, Ruiz Balda JA, Romeu Sarrió A, Caballero Fernández V, Cano Trigo I, Gómez Parga JL, et al. 2003. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial. BJOG 110:1072–1077.
  • Costello MF, Misso ML, Balen A, Boyle J, Devoto L, Garad RM, et al. 2019. Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility. Human Reproduction Open 2019:hoy021.
  • Dickey RP. 2009. Strategies to reduce multiple pregnancies due to ovulation stimulation. Fertility and Sterility 91:1–17.
  • Gorry A, White DM, Franks S. 2006. Infertility in polycystic ovary syndrome: focus on low-dose gonadotropin treatment. Endocrine 30:27–33.
  • Hayden CJ, Rutherford AJ, Balen AH. 1999. Induction of ovulation with the use of a starting dose of 50 units of recombinant human follicle-stimulating hormone (Puregon). Fertility and Sterility 71:106–108.
  • Hedon B, Hugues JN, Emperaire JC, Chabaud JJ, Barbereau D, Boujenah A, et al. 1998. A comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women. Human Reproduction 13:2688–2692.
  • Homburg R, Howles CM. 1999. Low-dose FSH therapy for anovulatory infertility associated with polycystic ovary syndrome: rationale, results, reflections and refinements. Human Reproduction Update 5:493–499.
  • Howles CM, Alam V, Tredway D, Homburg R, Warne DW. 2010. Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility. Reproductive Biomedicine Online 20:182–190.
  • Hugues JN, Cedrin-Durnerin I, Howles CM, Group FOS, Amram M, Angelini A, et al. 2006. The use of a decremental dose regimen in patients treated with a chronic low-dose step-up protocol for WHO Group II anovulation: a prospective randomized multicentre study. Human Reproduction 21:2817–2822.
  • Lan VT, Norman RJ, Nhu GH, Tuan PH, Tuong HM. 2009. Ovulation induction using low-dose step-up rFSH in Vietnamese women with polycystic ovary syndrome. Reproductive Biomedicine Online 18:516–521.
  • Leader A, Monofollicular Ovulation Induction Study Group. 2006. Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low-dose step-up protocol with weekly increments of 25 international units of follicle-stimulating hormone. Fertility and Sterility 85:1766–1773.
  • Mulders AG, Laven JS, Eijkemans MJ, Hughes EG, Fauser BC. 2003. Patient predictors for outcome of gonadotrophin ovulation induction in women with normogonadotrophic anovulatory infertility: a meta-analysis. Human Reproduction Update 9:429–449.
  • Orvieto R, Homburg R. 2009. Chronic ultra-low dose follicle-stimulating hormone regimen for patients with polycystic ovary syndrome: one click, one follicle, one pregnancy. Fertility and Sterility 91:1533–1535.
  • Papageorgiou TC, Guibert J, Savale M, Goffinet F, Fournier C, Merlet F, et al. 2004. Low dose recombinant FSH treatment may reduce multiple gestations caused by controlled ovarian hyperstimulation and intrauterine insemination. BJOG 111:1277–1282.
  • Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction 19:41–47.
  • Schoemaker J, Van Weissenbruch MM, Scheele F, Van Der Meer M. 1993. The FSH threshold concept in clinical ovulation induction. Bailliere's Clinical Obstetrics and Gynaecology 7:297–308.
  • Streda R, Mardesic T, Sobotka V, Koryntova D, Hybnerova L, Jindra M. 2012. Comparison of different starting gonadotropin doses (50, 75 and 100 IU daily) for ovulation induction combined with intrauterine insemination. Archives of Gynecology and Obstetrics 286:1055–1059.
  • Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. 2008. Consensus on infertility treatment related to polycystic ovary syndrome. Human Reproduction 23:462–477.
  • Van Rumste MM, Custers IM, Van Der Veen F, Van Wely M, Evers JL, Mol BW. 2008. The influence of the number of follicles on pregnancy rates in intrauterine insemination with ovarian stimulation: a meta-analysis. Human Reproduction Update 14:563–570.
  • White DM, Polson DW, Kiddy D, Sagle P, Watson H, Gilling-Smith C, et al. 1996. Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. The Journal of Clinical Endocrinology and Metabolism 81:3821–3824.
  • Yildizhan R, Adali E, Kolusari A, Kurdoglu M, Yildizhan B, Sahin HG, et al. 2008. Ovarian stimulation in obese and non-obese polycystic ovary syndrome using a low-dose step-up regimen with two different starting doses of recombinant follicle-stimulating hormone. The Journal of International Medical Research 36:1197–1204.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.